510(k) Report

510(k) · Cleared

Cleared

Phaseal

K023747510(k) SpecialCleared Nov 15, 20027-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Carmel Pharma Ab. · LHI Set, I.V. Fluid Transfer

Cleared on Nov 15, 2002 as substantially equivalent to K980381 (Carmel Pharma Ab., 1998) and 1 other predicate after a 7-day review. Its family tree reaches back 3 generations to 1988. 1 of the 45 devices in its family, counting itself, has a Class I recall. 38 later devices descend from it.

Decided
Nov 15, 2002
Review
7 days
Class
Class II
Product code
LHI
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K883614 (1988). 6 ancestors in all. 38 later devices descend from it, 2 citing it directly. 1 of the 45 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor1995: 1 other ancestor1994: 1 other ancestor2012: 1 descendant cleared2011: 1 descendant cleared2017: 3 descendants cleared2013: 3 descendants cleared, 1 with a Class I recall12024: 8 descendants cleared2020: 3 descendants cleared2014: 2 descendants cleared2018: 4 descendants cleared2015: 2 descendants cleared2021: 2 descendants cleared2025: 6 descendants cleared2023: 2 descendants cleared2022: 1 descendant clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor3 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants3 generations forward: 9 descendants, 1 with a Class I recall14 generations forward: 10 descendants5 generations forward: 10 descendants6 generations forward: 2 descendants7 generations forward: 1 descendant8 generations forward: 2 descendants K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 1998K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880+5
  1. Root · 3 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 2 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 1 generation backK980381 Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab. · 1998
  4. This deviceK023747 PhasealCarmel Pharma Ab. · 2002
  5. Descendant · cites it directly · 37 of its ownK110023 Infusion Adapter C100Carmel Pharma Ab. · 2011
  6. Descendant · cites it directly · 35 of its ownK120384 Protector, Injector, ConnectorBd Medical-Medical Surgical Systems · 2012
  7. Descendant · 2 generations on · 34 of its ownK123213 BD Phaseal Closed System Transfer DeviceBecton, Dickinson & CO · 2013 · Recalled
  8. Descendant · 3 generations on · 19 of its ownK130197 BD Phaseal Closed System Transfer Device - P55Becton, Dickinson and Company · 2013 · Recalled
  9. Descendant · 3 generations on · 10 of its ownK131549 Chemolock, Chemolock PortIcu Medical, Inc. · 2013 · Recalled (Class I)

Showing 5 of 38 descendants. See all descendants

Descendants cleared per year

2011: 12012: 12013: 32014: 22015: 22017: 32018: 42020: 32021: 22022: 12023: 22024: 82025: 6
2011high 8 (2024) · low 0 (2016)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 38 · See all
  • K110023Infusion Adapter C100Carmel Pharma Ab. · 2011 · cites it directly37descendants
  • K120384Protector, Injector, ConnectorBd Medical-Medical Surgical Systems · 2012 · cites it directly35descendants
  • K123213BD Phaseal Closed System Transfer DeviceBecton, Dickinson & CO · 2013 · 2 generations on34descendants
  • K130197BD Phaseal Closed System Transfer Device - P55Becton, Dickinson and Company · 2013 · 3 generations on19descendants
  • K131549Chemolock, Chemolock PortIcu Medical, Inc. · 2013 · 3 generations on10descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K883614Cytoguard (R)Survival Technology, Inc.1988—
−2K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−1K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab.1998—
0 (this device)K023747PhasealCarmel Pharma Ab.2002—
+1K110023Infusion Adapter C100Carmel Pharma Ab.2011—
+1K120384Protector, Injector, ConnectorBd Medical-Medical Surgical Systems2012—
+2K123213BD Phaseal Closed System Transfer DeviceBecton, Dickinson & CO20132
+3K130197BD Phaseal Closed System Transfer Device - P55Becton, Dickinson and Company20131
+3K131549Chemolock, Chemolock PortIcu Medical, Inc.2013Class I

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201210
201331
201420
201520
201730
201840
202030
202120
202210
202320
202480
202560
FIG. 1 — Lineage of K023747, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHI device

  1. #1 K252987 ADRx™ Admixture Devicescore 12.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration…
Summary page 1
…brane technique. Com parison of Predicate Devices/Equ ivalence The device is substantially equivalent to previously accepted PhaSeal devices included in 5 1O(k) Number K980381 and KOO1368. DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service…
Carmel Pharma Ab.1998—
*K001368Protector 21, Protector 50, Protector 14, Injector Luer Lock, Infusion AdapterCarmel Pharma Ab.20004

Also cleared against K980381: 6 other devices →

What descends from it? (38)

See all 38

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K110023Infusion Adapter C100Carmel Pharma Ab.201137
K120384Protector, Injector, ConnectorBd Medical-Medical Surgical Systems201235

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K131549Chemolock, Chemolock PortIcu Medical, Inc. · 2013 · 3 generations on · ◆ in the 2013 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 4.7 years on median.
  • 2 of the 6 ancestors have a recall of any class.
  • Of its descendants, K110023 (Carmel Pharma Ab., 2011) has gone furthest, with 37 descendants of its own.
  • 6 other devices also cite its predicate K980381.

How does its category compare?

All LHI devices

LHI Set, I.V. Fluid Transfer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LHI

6in 2025

2007: 32008: 42009: 82010: 52011: 32012: 52013: 42014: 62015: 32016: 32017: 52018: 12019: 42020: 32021: 32022: 62023: 52024: 92025: 62026 (partial year): 2
2007high 9 (2024) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHI

196in 2025

2007: 89 days median2008: 154 days median2009: 95 days median2010: 139 days median2011: 99 days median2012: 127 days median2013: 102 days median2014: 63 days median2015: 99 days median2016: 159 days median2017: 56 days median2019: 247 days median2020: 189 days median2021: 396 days median2022: 278 days median2023: 90 days median2024: 166 days median2025: 196 days median
2007high 396 (2021) · low 56 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LHI

1in 2024

2007: 12008: 32009: 12010: 32011: 122013: 32016: 1, 1 Class I2017: 12018: 3, 3 Class I2019: 12022: 22023: 2, 2 Class I2024: 12026 (partial year): 1
2007high 12 (2011) · low 0 (2012)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · LHI

1,334in 2025

2007: 182008: 272009: 372010: 492011: 1552012: 5292013: 1542014: 1552015: 1282016: 2192017: 5362018: 1,4992019: 1,6342020: 1,1712021: 9332022: 1,8342023: 1,0472024: 1,2702025: 1,334
2007high 1,834 (2022) · low 18 (2007)2025

MAUDE reports naming product code LHI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389118
20084154327
2009895137
20105139349
201139912155
201251270529
201341023154
20146630155
20153990128
201631591 (1)219
20175561536
20181—3 (3)1,499
2019424711,634
2020318901,171
202133960933
2022627821,834
20235902 (2)1,047
2024916611,270
2025619601,334
20262—1—

What is it indicated for?

The Infusion Adapter serves as a the connecting part between the IV bag and an external IV line (e.g. IV regulators). The Infusion Adapter has a built in Connector which makes it possible to admix drugs into the infusion solution using the sealed PhaSeal double membrane technique.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023747: Phaseal.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K023747

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026